Clinical Study of GPC3-targeted Autologous T Cells in Patients with Relapsed or Refractory Lung Cancer, Gastric Carcinoma and Breast Cancer

Trial Profile

Clinical Study of GPC3-targeted Autologous T Cells in Patients with Relapsed or Refractory Lung Cancer, Gastric Carcinoma and Breast Cancer

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs GPC3-CAR-T (Primary)
  • Indications Breast cancer; Gastric cancer; Lung cancer
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 24 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top